Uh Angers
Angers, 49933, France
NCT Number: NCT02834351
The purpose of this study is to evaluate the effect of muscle ischemia during claudication on mitochondrial function.
Comparison to patients with arterial disease but absence of lower limb claudication (Cardiac group) feasibility study.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Angers, 49933, France
Assess the feasibility of the study of micro-vascular function and mitochondrial on muscle sample (sartorius) in a group of arterial disease and non arteriopathy group.
Analysis of the activity of mitochondrial chain Immunochemistry of tissue markers
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A distal and proximal biopsy of the sartorius muscles ( 0.5 cm3 each) will be performed during surgery for saphenous vein withdrawal (cardiac group) or arterial bypass (PAD group) The samples are then treated with neurovascular and mitochondrial biology laboratory.
the activity of the complex 1 is analyzed and compared between the 2 groups.
Time frame: 1 week
Measurement of mitochondrial complex 1 activity (arbitrary units) on muscle biopsies by the laboratory of biochemistry. Comparison of the results observed on the same miuscle at the proximal level (assumed normal in both groups) and distal level (assumed ischemic in claudicants but not in cardiac patients without limb symptoms.
University Hospital, Angers
Other Gov
Atteinte Tissulaire au Cours de l'ischémie Chronique d'Effort. Validation d'un modèle d'étude du Muscle Sartorius Humain
Acronym: SARTORIUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05377320
Arterial Occlusive Diseases, Arteriosclerosis
Milwaukee, Wisconsin, United States
View Trial DetailsNCT02685098
Amputation, Arterial Occlusive Disease
Indianapolis, Indiana, United States
View Trial DetailsNCT00526474
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT02044666
Arterial Occlusive Diseases, Arteriosclerosis
Toronto, Ontario, Canada
View Trial Details